Article

Eligibility for hepatitis B virus (HBV) treatment and prevalence of drug resistance in a Ugandan population cohort

2025-04-07

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> The World Health Organization (WHO) 2024 Hepatitis B virus (HBV) treatment guidelines expand eligibility for nucleos(t)ide analogue treatment in individuals with chronic HBV infection. For countries to implement these guidelines, there is a critical need to understand the population who are treatment eligible. While HBV drug resistance (HBVDR) is uncommon, monitoring for any...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 90d1c38f-86ae-5612-b791-c568ef77889c
DOI: 10.1101/2025.04.06.25325341

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Eligibility for hepatitis B virus (HBV) treatment and prevalence of drug resistance in a Ugandan population cohortDOI 10.1101/2025.04.06.25325341Read

Hepatitis B: treatment choice and monitoring for response and resistance.Semantic proximity Read

Immune Escape and Drug Resistance Mutations in Patients with Hepatitis B Virus Infection: Clinical and Epidemiological ImplicationsSemantic proximity Read

A systematic review of Hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: a call for urgent actionSemantic proximity Read

Efficacy and Safety of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for The Treatment of Uncomplicated Plasmodium Falciparum Malaria and Prevalence of Molecular Markers Associated With Artemisinin and Partner Drug Resistance in UgandaSemantic proximity Read

Highly Diverse Hepatitis C Strains Detected in Sub‐Saharan Africa Have Unknown Susceptibility to Direct‐Acting Antiviral TreatmentsSemantic proximity Read

Micro-elimination of Hepatitis C virus (HCV) infection in the General Population Cohort in rural Uganda: long-term follow-up to assess feasibility and outcomes of a screening and treatment interventionSemantic proximity Read

A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: Data to inform clinical care and health policySemantic proximity Read

High Prevalence of Hepatitis B Virus Drug Resistance Mutations to Lamivudine Among People with HIV/HBV Coinfection in Rural and Peri-Urban Communities in BotswanaSemantic proximity Read

Evidence of Tenofovir Resistance in Chronic Hepatitis B Virus (HBV) Infection: An Observational Case Series of South African AdultsSemantic proximity Read

Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutationsSemantic proximity Read

High Prevalence of Hepatitis B Virus Drug Resistance Mutations to Lamivudine among People with HIV/HBV Coinfection in Rural and Peri-Urban Communities in Botswana.Semantic proximity Read

Antiviral drug resistance and hepatitis B: a continuing public health problem.Semantic proximity Read